Previous Close | 4.8500 |
Open | 4.8400 |
Bid | 4.7500 x 400 |
Ask | 4.8400 x 400 |
Day's Range | 4.7700 - 4.9450 |
52 Week Range | 3.5300 - 11.3600 |
Volume | |
Avg. Volume | 8,685,914 |
Market Cap | 671.075M |
Beta (5Y Monthly) | 1.58 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -5.4100 |
Earnings Date | May 07, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 15.40 |
Data from a late-stage study shows that Moderna's (MRNA) next-generation COVID vaccine induces a more robust immune response compared with its previously approved bivalent COVID vaccine.
Novavax, Inc. ( NASDAQ:NVAX ) missed earnings with its latest full-year results, disappointing overly-optimistic...
Novavax ( NASDAQ:NVAX ) Full Year 2023 Results Key Financial Results Revenue: US$983.7m (down 50% from FY 2022). Net...